CompletedNCT04874974
Feasibility of a Novel Process-based Treatment for Patients With Psychosis
Behavioural studyAges 18–70GermanySchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- MunichSee all locations and recruitment
Study information
Study start dateStarted: May 10, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 37
- Sponsor
- Max-Planck-Institute of Psychiatry
- Sponsor type
- Research institute
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention
- Study phase
- Not clearly listed
- Locations
- Germany
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT04874974
- Official title
Show the full official title
The PROBAS-Study: Developing a Process-based and Modular Group Therapy for Acute Psychiatric Patients With Psychotic Symptoms: a Single-arm Feasibility Study
Get this study by email
Recruitment & locations
CompletedMunich
Questions about this study
Who is behind this study?
The study sponsor is Max-Planck-Institute of Psychiatry, a research institute.
Who was this study for?
Listed age limits: 18 years to 70 years.
Want to explore more studies?
Explore studiesRelated studies
Effects of intranasal application of oxytocin on empathy and mentalising in patients with psychotic disorders and severe personality disorders
Blood Levels of Five Antipsychotic Medicines in People Receiving Psychiatric Care
